Related Experiment Video
Updated: Sep 13, 2025

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
Non-canonical Activation of RSK1 Induces EphA2-Mediated Cell Migration under Cellular Stress Conditions
Yue Zhou1, Fang Zhang1, Akihiro Tanaka1
1Department of Cancer Cell Biology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Toyama 930-0194, Japan.
Abstract:
p90 ribosomal S6 kinase 1 (RSK1) regulates various cellular events involved in cell growth and migration. We previously demonstrated that RSK1 catalyzes ephrin receptor A2 (EphA2) phosphorylation at Ser-897 to promote cancer cell migration, and that this pathway is regulated independently by extracellular signal-regulated kinase (ERK) and mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (MK2). Although the activation mechanism of RSK1 via ERK has been extensively examined, the mechanism for MK2 remains unclear. In the present study, we showed that MK2-mediated phosphorylation at Ser-380 in the linker region, a key mechanism of RSK1 activation, was dependent on the basal phosphorylation of Ser-221 in the N-terminal kinase domain. This basal phosphorylation was catalyzed by 3-phosphoinositide-dependent kinase 1 (PDK1) and was independent of ERK-catalyzed Ser-380 phosphorylation. The PDK1-MK2-RSK1-EphA2 axis promoted glioblastoma cell migration induced by temozolomide, a chemotherapeutic agent. Collectively, these results reveal a novel activation mechanism of RSK1 in cancer malignancy.
Insights
A novel pathway activates p90 ribosomal S6 kinase 1 (RSK1) through 3-phosphoinositide-dependent kinase 1 (PDK1) and mitogen-activated protein kinase-activated protein kinase 2 (MK2). This PDK1-MK2-RSK1-EphA2 axis drives glioblastoma cell migration, offering new insights into cancer malignancy.
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Research
Background:
- p90 ribosomal S6 kinase 1 (RSK1) is crucial for cell growth and migration.
- RSK1 phosphorylation of ephrin receptor A2 (EphA2) at Ser-897 promotes cancer cell migration.
- RSK1 activation is regulated by extracellular signal-regulated kinase (ERK) and mitogen-activated protein kinase-activated protein kinase 2 (MK2), with the MK2 pathway less understood.
Purpose of the Study:
- To elucidate the mechanism of RSK1 activation by MK2.
- To investigate the role of the PDK1-MK2-RSK1-EphA2 signaling axis in glioblastoma.
- To understand the contribution of this pathway to temozolomide-induced cell migration.
Main Methods:
- Investigated RSK1 phosphorylation sites, specifically Ser-380 and Ser-221.
- Utilized biochemical assays to determine kinase dependencies (PDK1, MK2, ERK).
- Examined the functional impact on glioblastoma cell migration in response to temozolomide.
Main Results:
- MK2-mediated RSK1 phosphorylation at Ser-380 requires basal phosphorylation at Ser-221.
- Ser-221 basal phosphorylation is catalyzed by 3-phosphoinositide-dependent kinase 1 (PDK1) and is independent of ERK.
- The PDK1-MK2-RSK1-EphA2 pathway significantly promotes glioblastoma cell migration induced by temozolomide.
Conclusions:
- Revealed a novel, PDK1-dependent activation mechanism for RSK1 via MK2.
- Identified a new signaling axis (PDK1-MK2-RSK1-EphA2) crucial for glioblastoma cell migration.
- This pathway represents a potential therapeutic target for enhancing chemotherapy efficacy in glioblastoma.
Related Concept Videos
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a...
Cell Polarization by Rho Proteins
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

